<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmccomplementalternmed&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Complementary and Alternative Medicine - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmccomplementalternmed/</link>
        <description>The latest research articles published by BMC Complementary and Alternative Medicine</description>
        <dc:date>2012-05-30T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/71" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/70" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/69" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/68" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/67" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/66" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/65" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/64" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/63" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/12/62" />
                            </rdf:Seq>
        </items>
                 <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/71">
        <title>Sesamin Stimulates Osteoblast Differentiation Through p38 and ERK1/2 MAPK Signaling Pathways</title>
        <description>Background:
Osteoporosisis a worldwide health problem predominantly affecting post-menopausal women. Therapies aimed at increasing bone mass in osteoporetic patients lag behind comparable investigation of therapeutic strategies focusing on the bone resorption process. Sesamin, a major lignan compound found in Sesamun indicum Linn., has  a variety of pharmacological effects, though its activity on bone cell function is unclear. Herein we examine the effect of this lignan on osteoblast differentiation and function.MethodCell cytotoxicity and proliferative in hFOB1.19 were examined by MTT and alamar blue assay up to 96 hour of treatment. Gene expression of COL1, ALP, BMP-2, Runx2, OC, RANKL and OPG were detected after 24 hour of sesamin treatment. ALP activity was measured at day 7, 14 and 21 of cultured. For mineralized assay, ADSCs were cultured in the presence of osteogenic media supplement with or without sesamin for 21 days and then stain with Alizarin Red S staining. MAPK signaling pathway activation was observed by using western blotting.
Results:
Sesamin promoted the expression COL1, ALP, OCN, BMP-2 and Runx2 in hFOB1.19.  On the other hand, sesamin was able to up-regulate OPG and down-regulate RANKL gene expression. ALP activity also significantly increased after sesamin treatment. Interestingly, sesamin induced formation of mineralized nodules in adipose derived stem cells (ADSCs) as observed by Alizarin Red S staining; this implies that sesamin has anabolic effects both on progenitor and committed cell stages of osteoblasts. Western blotting data showed that sesamin activated phosphorylation of p38 and ERK1/2 in hFOB1.19.
Conclusions:
The data suggest that sesamin has the ability to trigger osteoblast differentiation by activation of the MAPK signaling pathway (p38 and ERK) and possibly indirectly regulate osteoclast development via the expression of OPG and RANKL in osteoblasts. Therefore, sesamin may be a promising phytochemical that could be developed for osteoporotic therapy.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/71</link>
                <dc:creator>Orawan Wanachewin</dc:creator>
                <dc:creator>Kanchanit Boonmaleerat</dc:creator>
                <dc:creator>Peraphan Pothacharoen</dc:creator>
                <dc:creator>Vichai Reutrakul</dc:creator>
                <dc:creator>Prachya Kongtawelert</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:71</dc:source>
        <dc:date>2012-05-30T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-71</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-71-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>71</prism:startingPage>
        <prism:publicationDate>2012-05-30T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/70">
        <title>Rhodiola rosea for physical and mental fatigue: a systematic review </title>
        <description>Background:
Rhodiola rosea (R. rosea) is grown at high altitudes and northern latitudes. Due to its purported adaptogenic properties, it has been studied for its performance-enhancing capabilities in healthy populations and its therapeutic properties in a number of clinical populations.ObjectiveTo systematically review evidence of efficacy and safety of R.rosea for physical and mental fatigue.
Methods:
Six electronic databases were searched to identify randomized controlled trials (RCTs) and controlled clinical trials (CCTs), evaluating efficacy and safety of R. rosea for physical and mental fatigue. Two reviewers independently screened the identified literature, extracted data and assessed risk of bias for included studies.
Results:
Of 206 articles identified in the search, 11 met inclusion criteria for this review. Ten were described as RCTs and one as a CCT. Two of six trials examining physical fatigue in healthy populations report R.rosea to be effective as did three of five RCTs evaluating R. rosea for mental fatigue. All of the included studies exhibit either a high risk of bias or have reporting flaws that hinder assessment of their true validity (unclear risk of bias).
Conclusion:
Research regarding R.rosea efficacy is contradictory. While some evidence suggests that the herb may be helpful for enhancing physical performance and alleviating mental fatigue, methodological flaws limit accurate assessment of efficacy. A rigorously-designed well reported RCT that minimizes bias is needed to determine true efficacy of R.rosea for fatigue.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/70</link>
                <dc:creator>Sana Ishaque</dc:creator>
                <dc:creator>Larrisa Shamseer</dc:creator>
                <dc:creator>Cecilia Bukutu</dc:creator>
                <dc:creator>Sunita Vohra</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:70</dc:source>
        <dc:date>2012-05-29T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-70</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-70-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>70</prism:startingPage>
        <prism:publicationDate>2012-05-29T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/69">
        <title>The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines</title>
        <description>Background:
Saffron extract, a natural product, has been shown to induce apoptosis in several tumor cell lines. Nevertheless, the p53-dependency of saffron&apos;s mechanism of action in colon cancer remains unexplored.
Methods:
In order to examine saffron&apos;s anti-proliferative and pro-apoptotic effects in colorectal cancer cells, we treated two p53 isogenic HCT116 cell lines (HCT wildtype and HCT p53-/-) with different doses of the drug and analyzed cell proliferation and apoptosis in a time-dependent manner. MTT viability and crystal violet assays were performed in order to determine the effective dose of saffron on both cell lines. The cell cycle progress was examined by Flow cytometric analysis. Apoptosis was assessed using Annexin-PI-staining and Western Blotting for caspase 3 and PARP cleavage. Autophagy was determined by Western Blotting of the light chain 3 (LC3)-II and Beclin 1 proteins. The protein content of phospho-H2AX (gammaH2AX), a sensor of DNA double strand breaks, was also analyzed by Western Blotting.
Results:
Saffron extract induced a p53-dependent pattern of cell cycle distribution with a full G2/M stop in HCT116 p53 wildtype cells. However, it induced a remarkable delay in S/G2 phase transit with entry into mitosis in HCT116 p53 -/- cells. The apoptotic Pre-G1 cell fraction as well as Annexin V staining and caspase 3 cleavage showed a more pronounced apoptosis induction in HCT116 p53 wildtype cells. Obviously, the significantly higher DNA-damage, reflected by H2AX protein levels in cells lacking p53, was coped by up-regulation of autophagy. The saffron-induced LC3-II protein level was a remarkable indication of the accumulation of autophagosomes, a response to the cellular stress condition of drug treatment. Conclusions: This is the first study showing the effect of saffron in HCT116 colorectal cancer cells with different p53 status. Saffron induced DNA-damage and apoptosis in both cell lines. However, autophagy has delayed the induction of apoptosis in HCT116 p53 -/- cells. Considering the fact that most tumors show a functional p53 inactivation, further research is needed to elucidate the long-term effects of saffron in p53 -/- tumors.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/69</link>
                <dc:creator>Khuloud Bajbouj</dc:creator>
                <dc:creator>Jan Schulze-Luehrmann</dc:creator>
                <dc:creator>Stefanie Diermeier</dc:creator>
                <dc:creator>Amr Amin</dc:creator>
                <dc:creator>Regine Schneider-Stock</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:69</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-69</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-69-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>69</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/68">
        <title>Assessment of anti-depressant effect of Nelumbinis semen on rats under chronic mild stress and its subchronic oral toxicity in rats and Beagle dogs</title>
        <description>Background:
Previously, we examined the antidepressant effects of Nelumbinis Semen (NS). In this study, we assessed the anti-depressant effects of NS in the forced swimming test and chronic mild stress (CMS) models of depression and its oral toxicity in rats and dogs.
Methods:
In the forced swimming test, NS was intraperitoneally injected before 24 h, 5 h and 1h of forced swimming test. And the rats were forced to swim for 5 min, the duration of immobility was observed. In CMS models, animals were exposed to a variety of CMS for 8 weeks in order to induce depression-like symptoms. They were treated with NS for the last four weeks of the 8-week CMS and then an open field test was conducted. The anti-depression effects were evaluated based on a measured index, which consisted of visiting counts, start latency, rearing number and grooming time. In the toxicological studies, NS was administered to rats by gavages for 13 weeks at doses of 0, 500, 1000, and 2000 mg/kg/day. To assess the toxicity of NS in beagle dogs, NS was administered orally for 28 days at doses of 0, 500, 1000, 2000 and 4000 mg/kg/day.
Results:
400 mg/kg of NS had the lowest immobility times in forced swimming test. And NS significantly reversed the decreased visiting counts, rearing number and grooming time caused by CMS. In addition, NS treatment significantly decreased the start latency. No treatment-related toxicity was detected during 13 weeks administration in rats and 28 days administration in dogs.
Conclusions:
Based on the results of this study and previous reports that have examined the anti-depressive effects of NS, NS holds great promise for use in the treatment of depression without causing any adverse effects or toxicities.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/68</link>
                <dc:creator>Hwan-Suck Chung</dc:creator>
                <dc:creator>Hye Jeong Lee</dc:creator>
                <dc:creator>Insop Shim</dc:creator>
                <dc:creator>Hyunsu Bae</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:68</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-68</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-68-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>68</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/67">
        <title>Therapeutic effects of Radix Dipsaci, Pyrola Herb, and Cynomorium Songaricum on bone metabolism of ovariectomized rats</title>
        <description>Background:
It is not yet determined whether herbs can be used as alternative medicines for therapy of osteoporosis. The objective of this study was to evaluate the effects of herbal medicines, such as Radix Dipsaci (RDD), Pyrola Herb (PHD), and Cynomorium songaricum decoction (CSD), on osteoporotic rats induced by ovariectomy (OVX).
Methods:
OVX or sham operations were performed on 69 virgin Wistar rats that were divided into six groups: sham (sham, n = 12), OVX control group (OVX, n = 12), and OVX rats with treatments (diethylstilbestrol, DES, n = 12; RDD, n = 11, PHD, n = 11, and CSD, n = 11). Non-surgical rats served as normal control (NC, n = 12). The treatments began four weeks after surgery and lasted for 12 weeks. Bone mass and bone turnover were analyzed by histomorphometry. Levels of protein expression and mRNA of OPG and RANKL in osteoblasts (OB) and bone marrow stromal cells (bMSC) were evaluated by immunohistochemistry and in situ hybridization.
Results:
Compared to NC and sham rats, trabecular bone formation was significantly reduced in OVX rats, but restored in DES-treated rats. Treatment with either RDD or PHD enhanced trabecular bone formation remarkably. No significant change of bone formation was observed in CSD-treated rats. OPG expression of protein and mRNA was reduced significantly in OB and bMSC of OVX control rats. RANKL expression of protein and mRNA was increased significantly in OB and bMSC of OVX control rats. These effects were substantially reversed (increased in OPG and decreased in RANKL) by treatment with DES, RDD, or PHD in OB and bMSC of OVX rats. No significant changes in either OPG or RANKL expression were observed in OB and bMSC of OVX rats treated with CSD.
Conclusions:
Our study showed that RDD and PHD increased bone formation by stimulating overexpression of OPG and downregulation of RANKL in OB and bMSC. This suggests that RDD and PHD may be used as alternative therapeutic agents for postmenopausal osteoporosis.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/67</link>
                <dc:creator>Meijie Liu</dc:creator>
                <dc:creator>Gary XIAO</dc:creator>
                <dc:creator>Peijing Rong</dc:creator>
                <dc:creator>Zhiguo Zhang</dc:creator>
                <dc:creator>Jiazi Dong</dc:creator>
                <dc:creator>Hongyan Zhao</dc:creator>
                <dc:creator>Honghong Li</dc:creator>
                <dc:creator>Yan Li</dc:creator>
                <dc:creator>Jinghua Pan</dc:creator>
                <dc:creator>Hong Liu</dc:creator>
                <dc:creator>Wenlai Wang</dc:creator>
                <dc:creator>Qinglin Zha</dc:creator>
                <dc:creator>Dahong Ju</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:67</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-67</dc:identifier>
                            <dc:title>Chinese herbs counteract osteoporosis in rats</dc:title>
                            <dc:description>The traditional Chinese medical herbs Pyrola herb and Radix Dipsaci act via the RANKL/RANK/OPG pathway to counteract the reduction in bone formation caused by ovariectomy in rats, indicating their potential as therapeutic agents for postmenopausal osteoporosis.</dc:description>
                <prism:require>/content/figures/1472-6882-12-67-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>67</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/66">
        <title>The effect of yoga on women with secondary arm lymphoedema from breast cancer treatment.</title>
        <description>Background:
Women who develop secondary arm lymphoedema subsequent to treatment associated with breast cancer require life-long management for a range of symptoms including arm swelling, heaviness, tightness in the arm and sometimes the chest, upper body impairment and changes to a range of parameters relating to quality of life.  While exercise under controlled conditions has had positive outcomes, the impact of yoga has not been investigated. The aim of this study is to determine the effectiveness of yoga in the physical and psycho-social domains, in the hope that women can be offered another safe, holistic modality to help control many, if not all, of the effects of secondary arm lymphoedema.Methods and design: A randomised controlled pilot trial will be conducted in Hobart and Launceston with a total of 40 women receiving either yoga intervention or current best practice care.  Intervention will consist of eight weeks of a weekly teacher-led yoga class with a home-based daily yoga practice delivered by DVD. Primary outcome measures will be the effects of yoga on lymphoedema and its associated symptoms and quality of life.  Secondary outcome measures will be range of motion of the arm and thoracic spine, shoulder strength, and weekly and daily physical activity.  Primary and secondary outcomes will be measured at baseline, weeks four, eight and a four week follow up at week twelve.  Range of motion of the spine, in a self-nominated group, will be measured at baseline, weeks eight and twelve.  A further outcome will be the women&apos;s perceptions of the yoga collected by interview at week eight.DiscussionThe results of this trial will provide information on the safety and effectiveness of yoga for women with secondary arm lymphoedema from breast cancer treatment. It will also inform methodology for future, larger trials.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/66</link>
                <dc:creator>Annette Loudon</dc:creator>
                <dc:creator>Tony Barnett</dc:creator>
                <dc:creator>Neil Piller</dc:creator>
                <dc:creator>Maarten Immink</dc:creator>
                <dc:creator>Denis Visentin</dc:creator>
                <dc:creator>Andrew Williams</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:66</dc:source>
        <dc:date>2012-05-28T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-66</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-66-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>66</prism:startingPage>
        <prism:publicationDate>2012-05-28T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/65">
        <title>Antioxidant and gastric cytoprotective prostaglandins properties of Cassia sieberiana roots bark extract as an anti-ulcerogenic agent.</title>
        <description>Background:
Cassia sieberiana is a savannah tree with a wide phytotherapeutic application including the use of its roots in the management of various stomach disorders including gastric ulcer, stomach pains and indigestion. The aim of the study is to evaluate the antioxidant, gastric cytoprotective prostaglandins, secretory phospholipase A2, phytochemical and acute toxicity properties of Cassia sieberiana roots bark extract in a bid to justify its phytotherapeutic applications in gastric ulcer.
Methods:
Antioxidant and radical scavenging activities of the roots bark extract of Cassia sieberiana were assayed. Serum secretory phospholipase A2 (sPLA2) concentration and activity and the formation of gastric mucosal prostaglandins E2 (PGE2) and I2 (PGI2) were also assessed. Comparisons between means were performed using analysis of variance (ANOVA) followed by Students Standard Newman-Keuls post hoc analysis to determine statistical significance. P&lt;0.05 was considered significant.
Results:
The extract was found to possess significant ferric reducing antioxidant power and can scavenge hydroxyl radicals. The extract also possesses DPPH scavenging activity, can chelate ferrous ion and a dose-dependent protective effect against lipid peroxidation and free radical generation. Prostaglandin studies showed that the roots bark extract dose dependently increased gastric mucosal PGE2 and PGI2 levels and also decreased serum sPLA2 activity. Phytochemical analyses suggest that the roots extract contains polyhydroxyl/phenolic substances. Acute toxicity test showed no sign of toxicity up to a dose level of 2000 mg/kg body weight p.o.
Conclusions:
C. sieberiana roots extract possesses significant antioxidant and gastric cytoprotective prostaglandin properties as well as serum secretory phospholipase A2 inhibitory activity which could be due to its content of polyhydroxy and/or phenolic substances. This may justify its use as an anti-ulcerogenic agent in traditional medicine in West Africa.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/65</link>
                <dc:creator>Edmund Nartey</dc:creator>
                <dc:creator>Mark Ofosuhene</dc:creator>
                <dc:creator>William Kudzi</dc:creator>
                <dc:creator>Caleb Agbale</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:65</dc:source>
        <dc:date>2012-05-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-65</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-65-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>65</prism:startingPage>
        <prism:publicationDate>2012-05-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/64">
        <title>Baicalin, a natural compound, promotes regulatory T cell differentiation </title>
        <description>Background:
CD4+CD25+Foxp3+ regulatory T (Treg) cells inhibit autoimmunity and protect against tissue injury. The development of these Treg cells is controlled by the regulator protein Foxp3, which can be enhanced by the in vitro activation of Foxp3 in the presence of transforming growth factor-beta. However, little is known about alternative methods, such as the use of natural products, for controlling Foxp3-mediated Treg cell differentiation.MethodHEK 293T cells were transfected with Foxp3 expression plasmid, and then treated with different compounds, Foxp3 mRNA expression was determined by real-time RT-PCR. CD4+CD25-T cells were stimulated with Baicalin, Foxp3 protein expression were analyzed by flow cytometry and confocal microscopy, the regulatory function of T cells stimulated with Baicalin was detected by the carboxyfluorescien succinimidyl ester.
Results:
We demonstrated that Baicalin, a compound isolated from the Chinese herb Huangqin, induced Foxp3 protein expression in cultured T cells, promoted Treg cell differentiation and regulatory activity. Our data also indicated that Baicalin restored Foxp3 expression following its initial interleukin-6-mediated inhibition and induced Foxp3 expression in vitro.
Conclusions:
These data suggest that Baicalin may promote Treg cell differentiation and regulatory activity and may serve as a promising natural immunosuppressive compound for treating autoimmune inflammatory diseases.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/64</link>
                <dc:creator>ji yang</dc:creator>
                <dc:creator>xue yang</dc:creator>
                <dc:creator>ming li</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:64</dc:source>
        <dc:date>2012-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-64</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-64-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>64</prism:startingPage>
        <prism:publicationDate>2012-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/63">
        <title>Hypoglycemic and antilipidemic properties of kombucha tea in alloxan-induced diabetic rats</title>
        <description>Background:
Diabetes has become a serious health problem and a major risk factor associated with troublesome health complications, such as metabolism disorders and liver-kidney dysfunctions. The inadequacies associated with conventional medicines have led to a determined search for alternative natural therapeutic agents. The present study aimed to investigate and compare the hypoglycemic and antilipidemic effects of kombucha and black tea, two natural drinks commonly consumed around the world, in surviving diabetic rats.
Methods:
Alloxan diabetic rats were orally supplied with kombucha and black tea at a dose of 5 mL/kg body weight per day for 30 days, fasted overnight, and sacrificed on the 31st day of the experiment. Their bloods were collected and submitted to various biochemical measurements, including blood glucose, cholesterol, triglcerides, urea, creatinine, transaminases, transpeptidase, lipase, and amylase activities. Their pancreases were isolated and processed to measure lipase and alpha-amylase activities and to perform histological analysis.
Results:
The findings revealed that, compared to black tea, kombucha tea was a better inhibitor of alpha-amylase and lipase activities in the plasma and pancreas and a better suppressor of increased blood glucose levels. Interestingly, kombucha was noted to induce a marked delay in the absorption of LDL-cholesterol and triglycerides and a significant increase in HDL-cholesterol.  Histological analyses also showed that it exerted an ameliorative action on the pancreases and efficiently protected the liver-kidney functions of diabetic rats, evidenced by significant decreases in aspartate transaminase, alanine transaminase, and gamma-glytamyl transpeptidase activities in the plasma, as well as in the creatinine and urea contents.
Conclusions:
The findings revealed that kombucha tea administration induced attractive curative effects on diabetic rats, particularly in terms of liver-kidney functions. Kombucha tea can, therefore, be considered as a potential strong candidate for future application as a functional supplement for the treatment and prevention of diabetes.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/63</link>
                <dc:creator>Ahmed Aloulou</dc:creator>
                <dc:creator>Khaled Hamden</dc:creator>
                <dc:creator>Dhouha Elloumi</dc:creator>
                <dc:creator>Madiha Bou Ali</dc:creator>
                <dc:creator>Khaoula Hargafi</dc:creator>
                <dc:creator>Bassem Jaouadi</dc:creator>
                <dc:creator>Fatma Ayadi</dc:creator>
                <dc:creator>Abdelfettah El Feki</dc:creator>
                <dc:creator>Emna Ammar</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:63</dc:source>
        <dc:date>2012-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-63</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-63-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>63</prism:startingPage>
        <prism:publicationDate>2012-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1472-6882/12/62">
        <title>Dietary intervention with narrow-leaved cattail rhizome flour 
(Typha angustifolia L.) prevents intestinal inflammation in the trinitrobenzenesulphonic acid model of rat colitis

</title>
        <description>Background:
Inflammatory bowel disease (IBD) is a chronic inflammation of the intestinal epithelium that is driven by the intestinal immune system, oxidative stress and the loss of tolerance to the luminal microbiota. The use of dietary products containing ingredients such as fibres and carbohydrates and/or antioxidant compounds have been used as a therapeutic strategy for intestinal diseases because these products are considered effective in the modulation of the immune system and colonic microbiota. We investigated the beneficial effects of cattail rhizome flour (Typha angustifolia L.) in the trinitrobenzenesulphonic acid (TNBS) model of rat colitis. In addition, we investigated the effects of cattail rhizome flour on the intestinal anti-inflammatory activity of prednisolone, which is a reference drug that is used for treatment of human IBD.
Methods:
The present study included the preparation of flour from rhizomes of cattail (Typha angustifolia L.); an evaluation of the qualitative phytochemical profile of cattail rhizomes; an evaluation of the efficacy of cattail rhizome flour in TNBS-induced rat colitis; an evaluation of the synergistic effects of cattail rhizome flour on the intestinal anti-inflammatory activity of prednisolone; and macroscopic, clinical, biochemical, histopathological and microbiological studies to assess the healing effects of cattail rhizome flour and its synergistic effects in TNBS-induced rat colitis. The data were analysed by ANOVA, Kruskal-Wallis and chi2 tests.
Results:
We tested several concentrations of cattail rhizome flour and found that dietary supplementation with 10% cattail rhizome flour showed the best effects at reducing the extension of the lesion, the colon weight ratio, adherences to adjacent organs and diarrhoea. These effects were related to inhibition of myeloperoxidase (MPO) and alkaline phosphatase (AP) activities and an attenuation of glutathione (GSH) depletion. The 10% cattail rhizome flour was as effective as prednisolone, and no synergistic effects were observed. Saponins, flavonoids and coumarins were detected in the rhizome flour. No changes were observed in the total number of lactic bacteria after dietary supplementation with cattail rhizome flour.
Conclusions:
Dietary supplementation with 10% cattail rhizome flour and its combination with prednisolone prevent TNBS-induced colonic damage in rats, but no synergistic effects were observed. The prevention of TNBS-induced colon damage was associated with an improvement in intestinal oxidative stress, which likely resulted from the antioxidant properties of the active compounds detected in the cattail rhizome. This protective effect was not related to an improvement in lactic bacteria counts.</description>
        <link>http://www.biomedcentral.com/1472-6882/12/62</link>
                <dc:creator>Andrea Fruet</dc:creator>
                <dc:creator>Leonardo Seito</dc:creator>
                <dc:creator>Vera Rao</dc:creator>
                <dc:creator>Luiz Di Stasi</dc:creator>
                <dc:source>BMC Complementary and Alternative Medicine 2012, null:62</dc:source>
        <dc:date>2012-05-04T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1472-6882-12-62</dc:identifier>
                                <prism:require>/content/figures/1472-6882-12-62-toc.gif</prism:require>
                <prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
        <prism:issn>1472-6882</prism:issn>
        <prism:volume>${item.volume}</prism:volume>
        <prism:startingPage>62</prism:startingPage>
        <prism:publicationDate>2012-05-04T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>

